Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.9900
-0.0300 (-2.94%)
At close: Aug 1, 2025, 4:00 PM
1.030
+0.040 (4.04%)
After-hours: Aug 1, 2025, 7:25 PM EDT
Accolade Market Cap
Oncolytics Biotech has a market cap or net worth of $95.91 million as of August 1, 2025. Its market cap has increased by 22.95% in one year.
Market Cap
95.91M
Enterprise Value
85.54M
1-Year Change
22.95%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since November 8, 1999, Oncolytics Biotech's market cap has increased from $13.94M to $95.91M, an increase of 587.77%. That is a compound annual growth rate of 7.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 95.91M | 34.62% |
| Dec 31, 2024 | 71.24M | -28.39% |
| Dec 29, 2023 | 99.49M | 2.75% |
| Dec 30, 2022 | 96.82M | 27.24% |
| Dec 31, 2021 | 76.10M | -25.88% |
| Dec 31, 2020 | 102.67M | -17.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |